Neogenomics (NEO) Other Non-Current Assets (2010 - 2026)
Neogenomics (NEO) posted Other Non-Current Assets of $9.6 million for Q1 2026, up 2.14% quarter-over-quarter from $9.4 million in Q4 2025, and up 59.73% year-on-year from $6.0 million in Q1 2025.
Neogenomics (NEO) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has reported Other Non-Current Assets for 16 consecutive years, with $9.6 million the latest figure, recorded in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $9.6 million, up 59.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.6 million (up 59.73% YoY), and the FY2025 annual result was $9.4 million, up 59.6% from the prior year.
- Other Non-Current Assets was $9.6 million for Q1 2026 at Neogenomics, up from $9.4 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $9.6 million in Q1 2026 and troughed at $4.1 million in Q2 2024.
- Average Other Non-Current Assets over 5 years is $6.2 million, with a median of $5.9 million recorded in 2024.
- Year-over-year, Other Non-Current Assets slumped 40.64% in 2022 and soared 74.9% in 2025.
- Over 5 years, Other Non-Current Assets stood at $5.1 million in 2022, then dropped by 7.18% to $4.7 million in 2023, then gained by 24.12% to $5.9 million in 2024, then soared by 59.6% to $9.4 million in 2025, then grew by 2.14% to $9.6 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $9.6 million in Q1 2026, $9.4 million in Q4 2025, and $8.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 498.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 5.97 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 4.21 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 552.79 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 51.00 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 1.18 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 489.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 523.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 454.16 Mn |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | 9.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.60 Mn |
| Dec 31, 2025 | 9.39 Mn |
| Sep 30, 2025 | 8.19 Mn |
| Jun 30, 2025 | 7.13 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Dec 31, 2024 | 5.89 Mn |
| Sep 30, 2024 | 5.58 Mn |
| Jun 30, 2024 | 4.08 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | 4.74 Mn |
| Sep 30, 2023 | 4.97 Mn |
| Jun 30, 2023 | 5.41 Mn |
| Mar 31, 2023 | 5.31 Mn |
| Dec 31, 2022 | 5.11 Mn |
| Sep 30, 2022 | 6.85 Mn |
| Jun 30, 2022 | 6.38 Mn |
| Mar 31, 2022 | 6.60 Mn |
| Dec 31, 2021 | 7.17 Mn |
| Sep 30, 2021 | 7.21 Mn |
| Jun 30, 2021 | 4.10 Mn |